Latest News
Skye Bioscience, Inc.
- Skye Bioscience, Inc. Estimates – LSX:A42JP2
- TANG CAPITAL MANAGEMENT LLC Acquires 263,560 Shares of Skye Bios
- Redx Pharma expects $125million Skye Bioscience deal to complete soon
- Skye Bioscience director Andrew Schwab sells $239,555 in common stock
Headlines from the last 30 days, linking to the original publishers. See all market news →